Comparison of orciprenaline, ephedrine and methoxyphenamine as oral bronchodilators.
D000293:Adolescent; D000328:Adult; D001249:Asthma / Q000188:drug therapy*; D001993:Bronchodilator Agents / Q000494:pharmacology / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D004809:Ephedrine / Q000494:pharmacology / Q000627:therapeutic use*; D005260:Female; D006339:Heart Rate / Q000187:drug effects; D006801:Humans; D008297:Male; D009921:Metaproterenol / Q000494:pharmacology / Q000627:therapeutic use*; D008744:Methylamines / Q000494:pharmacology / Q000627:therapeutic use; D008875:Middle Aged; D010627:Phenethylamines / Q000494:pharmacology / Q000627:therapeutic use*; D010919:Placebos; D012123:Pulmonary Ventilation / Q000187:drug effects; D013147:Spirometry; D014797:Vital Capacity / Q000187:drug effects
D001993:Bronchodilator Agents; D008744:Methylamines; D010627:Phenethylamines; D010919:Placebos; D009921:Metaproterenol; D004809:Ephedrine